Clinical trial
A Prospective Cohort Study of Treatment Response in Sjogren's Syndrome-Related Lung Diseases Compared to Primary Idiopathic Lung Diseases
NCT04843345 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Cohort Study of Treatment Response in Sjogren's Syndrome-Related Lung Diseases Compared to Primary Idiopathic Lung Diseases
- Lead sponsor
- Stanford University
- Phase
- Observational
- Overall status
- Suspended
- Start date
- April 1, 2021
- Completion date
- April 1, 2030
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bronchiectasis, chronic bronchiolitis, cystic lung disease, interstitial lung disease, lung diseases, lymphocytic interst. pneumonitis, primary pulmonary lymphoma (disorder), sjogren's syndrome